Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?
Dividend investors are usually drawn like moths to high-yield stocks. That makes total sense, but a string of recent dividend cuts announced by companies like Conagra (NYSE: CAG) and Campbell's (NASDAQ: CPB) in the historically resilient consumer staples sector should leave dividend lovers on edge. In the pharmaceutical space, another sector known for resilience, two of the highest-yielding stocks are Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) , with yields of 6% and 4.7%, respectively. Which one is the better choice? Image source: Getty Images. Continue reading